2018
DOI: 10.7150/thno.26607
|View full text |Cite
|
Sign up to set email alerts
|

Hypoxia-triggered single molecule probe for high-contrast NIR II/PA tumor imaging and robust photothermal therapy

Abstract: Hypoxia is a common characteristic of solid tumors. This important feature is associated with resistance to radio-chemotherapy, which results in poor prognosis and probability of tumor recurrence. Taking advantage of background-free NIR II fluorescence imaging and deeper-penetrating photoacoustic (PA) imaging, we developed a hypoxia-triggered and nitroreductase (NTR) enzyme-responsive single molecule probe for high-contrast NIR II/PA tumor imaging and hypoxia-activated photothermal therapy (PTT), which will ov… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
157
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 195 publications
(158 citation statements)
references
References 60 publications
1
157
0
Order By: Relevance
“…With regards to the potential use of hypoxia probes in the clinic, Image-iT TM works within the NIR I region, thus limiting the depth and localization of the fluorescence source due to biological interference [34], and it is only used pre-clinically. However, a new generation of hypoxia probes are currently under development to operate within the NIR II region (1000 -1700 nm), drastically improving in vivo spatial resolution, signal-to-noise ratio and tissue penetration [35]. Also, current developments in clinical photoacoustic imaging may soon allow the use of such probes in the clinic [35].…”
Section: Discussionmentioning
confidence: 99%
“…With regards to the potential use of hypoxia probes in the clinic, Image-iT TM works within the NIR I region, thus limiting the depth and localization of the fluorescence source due to biological interference [34], and it is only used pre-clinically. However, a new generation of hypoxia probes are currently under development to operate within the NIR II region (1000 -1700 nm), drastically improving in vivo spatial resolution, signal-to-noise ratio and tissue penetration [35]. Also, current developments in clinical photoacoustic imaging may soon allow the use of such probes in the clinic [35].…”
Section: Discussionmentioning
confidence: 99%
“…The NIR‐II QY of FD‐1080 was tested to be 0.31% and could be elevated to 5.94% in FBS buffer. Increasing cyanine NIR‐II dyes have appeared in academic literature through structure redesigning or modifying …”
Section: Synthesis and Chemical Structures Of Nir Dyesmentioning
confidence: 99%
“…Nowadays, PTT has been widely used for tumor treatment by using various photothermal agents, such as Au nanomaterials, organic dyes and polymer semiconductors. [ 50,51,67,66,118 ] In 2019, Yan and Wang et al developed a macromolecular fluorophore (PF) nanoparticle using an amphiphilic polypeptide‐conjugated NIR‐II fluorophore (Flav7) ( Figure a–g). [ 118 ] The synthesized PF nanoparticles showed satisfactory photothermal conversion efficiency (42.3%) and excellent photothermal stability.…”
Section: Advanced Nir Light For Spatiotemporal Modulation Of Cell Funmentioning
confidence: 99%
“…Recently, the dual‐functional strategies have been successfully applied in cancer diagnosis and therapy. [ 67,66 ]…”
Section: Nir Light For Simultaneous Cell Sensing and Modulationmentioning
confidence: 99%